Ignite Creation Date:
2025-12-24 @ 2:47 PM
Ignite Modification Date:
2026-02-23 @ 11:34 AM
Study NCT ID:
NCT04064359
Status:
RECRUITING
Last Update Posted:
2025-09-16
First Post:
2019-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors
Sponsor:
Oxford BioTherapeutics Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-25
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-08-16
First Submit QC Date:
None
Study First Post Date:
2019-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-09
Last Update Post Date:
2025-09-16
Last Update Post Date Type:
ESTIMATED